In this video update on January 22, 2021, COO and President, Matthew Mills reports to all shareholders on the revenue momentum that is carrying over into 2021. He explains in detail why the Company is having its best January in its history as well as discusses some exciting news in regarding the details, including our new relationships that are bringing the Nature-Cide products into Mexico, Australia, Sri Lanka and the Caribbean.
There are a lot of moving parts with this business, so please watch the video and check the news and updates section in your investor dashboard regularly, as communications will be increasing as the Company moves forward.
We are excited to report that revenue is exceeding our expectations already this year. This is the best start to a year the Company has had and we are hopeful this is setting the tone for the rest of the year.
The investment banks, VC’s and other groups who are closely watching us are very excited that we jumped out of the gate like this. We are all focused on continuing the momentum.
As we have discussed at length in previous updates, the fruits of our labor and the investment to get the necessary toxicity testing for Nature-Cide completed is paying off. Although we still need more testing to go into a few larger markets, the first round of testing has allowed us to start the positioning into the following regions.
Mexico
Australia
Sri Lanka
Caribbean
The best part of this is that the partners we are engaging with have vast experience and are convinced from their personal testing of the products, that Nature-Cide’s methods and products are a pure winning combination. We are excited to announce we have committed to exclusivity contracts based on performance with these well known and trusted entities.
See the video for details about these Partner Companies.
Not only will these very large companies be using the products in their portfolios of offerings to their customers, but they will be incentivized to sell and distribute the Nature-Cide products nationwide to all other pest control companies, just like we do here in the USA. These partners will act as an extension of the Nature-Cide team in the US and will allow us to gain access to these regions with little barrier to entry.
. Matthew is working diligently with the team from the NewChip Accelerator to become more educated to ensure we provide the necessary assets to begin the process of promoting the Med-X project all over the globe. Our engagements with both US Capital Global and The NewChip Accelerator will allow the Company to better target the investment banking groups that invest in projects in the EcoTech sector, like Med-X.
As Matthew states in the video, “we are not messing around.” As soon as we are able to secure the capital, the Company will begin the expansion process by planning to move forward towards an IPO to fuel and supersize the marketing efforts of the products, and launch a well thought out M&A strategy, which management believes will allow the Company to hold sizable market capitalization.
Your continued support and engagement is really catching the eyes of some potential large investors. They love the fact that we have such an incredible community. It's very important that we keep up the momentum in all departments, as the investment banking community moves a little faster when they see something that is always fast paced.
Thank you for all your continued support.
To increase your position, please click the INVEST NOW button on the website or log into your INVESTOR DASHBOARD.
If you are still having issues accessing your Investor Dashboard email us info@med-rx.com.
Happy New Year!
DISCLAIMER AND FORWARD-LOOKING STATEMENTS
The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company.
This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.